Multifunctional scaffolds for bone repair following age-related biological decline: Promising prospects for smart biomaterial-driven technologies
Biomaterials,
Journal Year:
2024,
Volume and Issue:
311, P. 122683 - 122683
Published: June 28, 2024
Language: Английский
Advances in self-assembled nanotechnology in tumor therapy
Yanting Kuang,
No information about this author
Zhaokai Li,
No information about this author
Hang Chen
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2024,
Volume and Issue:
237, P. 113838 - 113838
Published: March 11, 2024
Language: Английский
Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations
Zhen Luo,
No information about this author
Yuxin Jiang,
No information about this author
Zimo Liu
No information about this author
et al.
Nano Research,
Journal Year:
2024,
Volume and Issue:
17(7), P. 6332 - 6341
Published: March 13, 2024
Language: Английский
Photothermal-Magnetic Driven Post-Targeting Retention and Cascade Therapy of “Biomimetic Glue”-Based Nanoreactor for Cancer Theranostics by Bystander-Like Killing
Zihan Liu,
No information about this author
Ting Yang,
No information about this author
Jiale Miao
No information about this author
et al.
Published: Jan. 1, 2025
Language: Английский
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen,
No information about this author
Dhanshree Vikrant Konde,
No information about this author
Safal Kumar Paikray
No information about this author
et al.
Exploration of Targeted Anti-tumor Therapy,
Journal Year:
2025,
Volume and Issue:
6
Published: April 10, 2025
Immunotherapy
has
gathered
significant
attention
and
is
now
a
widely
used
cancer
treatment
that
uses
the
body's
immune
system
to
fight
cancer.
Despite
initial
successes,
its
broader
clinical
application
hindered
by
limitations
such
as
heterogeneity
in
patient
response
challenges
associated
with
tumor
microenvironment.
Recent
advancements
nanotechnology
have
offered
innovative
solutions
these
barriers,
providing
enhancements
immunotherapy.
Nanotechnology-based
approaches
exhibit
multifaceted
mechanisms,
including
effective
anti-tumor
responses
during
tumorigenesis
overcoming
suppression
mechanisms
improve
defense
capacity.
Nanomedicines,
nanoparticle-based
vaccines,
liposomes,
modulators,
gene
delivery
systems,
demonstrated
ability
activate
responses,
modulate
microenvironments,
target
specific
cells.
Success
metrics
preclinical
early
studies,
improved
survival
rates,
enhanced
regression,
elevated
activation
indices,
highlight
promise
of
technologies.
achievements,
several
remain,
scaling
up
manufacturing,
addressing
off-target
effects,
navigating
regulatory
complexities.
The
review
emphasizes
need
for
interdisciplinary
address
ensuring
adoption.
It
also
provides
insights
into
approaches,
advancements,
transformative
potential
nano-immunotherapy
promising
results
checkpoint
inhibitor
delivery,
nanoparticle-mediated
photothermal
therapy,
immunomodulation
well
inhibition
nanoparticles
vaccines.
Language: Английский
Photothermal-magnetic driven post-targeting retention and cascade therapy of “biomimetic glue”-based nanoreactor for cancer theranostics by bystander-like killing
Zihan Liu,
No information about this author
Ting Yang,
No information about this author
Jiale Miao
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 162784 - 162784
Published: April 1, 2025
Language: Английский
Nanomedicine for cancer patient‐centered care
MedComm,
Journal Year:
2024,
Volume and Issue:
5(11)
Published: Oct. 20, 2024
Abstract
Cancer
is
a
leading
cause
of
morbidity
and
mortality
worldwide,
an
increase
in
incidence
estimated
the
next
future,
due
to
population
aging,
which
requires
development
highly
tolerable
low‐toxicity
cancer
treatment
strategies.
The
use
nanotechnology
tailor
treatments
according
genetic
immunophenotypic
characteristics
patient's
tumor,
allow
its
targeted
release,
can
meet
this
need,
improving
efficacy
minimizing
side
effects.
Nanomedicine‐based
approach
for
diagnosis
rapidly
evolving
field.
Several
nanoformulations
are
currently
clinical
trials,
some
have
been
approved
marketed.
However,
their
large‐scale
production
still
hindered
by
in‐depth
debate
involving
ethics,
intellectual
property,
safety
health
concerns,
technical
issues,
costs.
Here,
we
survey
key
approaches,
with
specific
reference
organ‐on
chip
technology,
cutting‐edge
tools,
such
as
CRISPR/Cas9
genome
editing,
through
nanosystems
needs
personalized
diagnostics
therapy
patients.
An
update
provided
on
nanopharmaceuticals
marketed
those
undergoing
trials.
Finally,
discuss
emerging
avenues
field
challenges
be
overcome
transfer
nano‐based
precision
oncology
into
daily
life.
Language: Английский
Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
Yun Yang,
No information about this author
Seewoo Kim,
No information about this author
Sang‐Nam Lee
No information about this author
et al.
Nano Convergence,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: Dec. 13, 2024
Abstract
Nanomaterials
have
emerged
as
transformative
tools
for
detecting
circulating
tumor
cells
(CTCs)
and
cancer
stem
(CCSCs),
significantly
enhancing
diagnostics
immunotherapy.
Nanomaterials,
including
those
composed
of
gold,
magnetic
materials,
silica,
enhanced
the
sensitivity,
specificity,
efficiency
isolating
these
rare
from
blood.
These
developments
are
paramount
importance
early
detection
providing
real-time
insights
into
metastasis
treatment
resistance,
which
essential
development
personalized
immunotherapies.
The
combination
nanomaterial-based
platforms
with
phenotyping
techniques,
such
Raman
spectroscopy
microfluidics,
enables
researchers
to
enhance
immunotherapy
protocols
targeting
specific
CTC
CCSC
markers.
also
facilitate
targeted
delivery
immunotherapeutic
agents,
immune
checkpoint
inhibitors
therapeutic
antibodies,
directly
cells.
This
synergistic
approach
has
potential
efficacy
mitigate
risk
relapse.
In
conclusion,
this
review
critically
examines
use
nanomaterial-driven
systems
CTCs
CCSCs,
their
application
in
immunotherapy,
suggests
future
directions,
highlighting
transform
integration
treatment,
thereby
paving
way
more
precise
therapies.
Graphical
Language: Английский
静电纺丝技术制备聚合物基MXene增强电磁屏蔽复合材料的研究进展
ZhiYong ZENG,
No information about this author
Feng Cao,
No information about this author
Jian Huang
No information about this author
et al.
Scientia Sinica Technologica,
Journal Year:
2024,
Volume and Issue:
54(8), P. 1496 - 1518
Published: June 21, 2024
随着电子信息技术的发展,电磁波污染已经严重影响了人类健康和社会进步,因此急需开发出一种高效的电磁干扰(electromagnetic
interference,EMI)屏蔽材料。静电纺丝技术可以制备出柔韧性好的超薄多孔纤维膜,电磁波能够在纤维膜内部进行多次反射而被消耗。MXene作为一种新型的二维(2D)材料群体,具有高比表面积、高导电性以及易加工性,是一种潜在的EMI屏蔽材料。因此,将静电纺丝技术和MXene材料相结合,能够制备出多功能的聚合物基MXene增强电磁屏蔽复合材料。本文首先介绍了静电纺丝技术的概念、原理及其影响因素,其次,分析了MXene材料的组成和制备方法,最后,讨论了静电纺丝技术制备聚合物基MXene增强电磁屏蔽复合材料的最新进展并对未来聚合物基MXene增强静电纺丝复合材料在电磁屏蔽领域的发展做出展望。